Despite the overall improvement in the health of Americans during the past two decades, significant disparities in health outcomes persist based on race and ethnicity, sex, level of education and income, and other social characteristics. There is a growing awareness in many segments of United States society that persistent health disparities are not acceptable, and that through, coordinated and targeted actions most health disparities are correctable. Created in 2005 with partial funding as an EXPORT Center, for the past six years the Texas Center for Health Disparities (TCHD) has been a leader in health disparities research, education, and outreach In its local community, throughout the State of Texas, and in many parts of the nation. Building on its significant experience and expansive relationships, the TCHD and its partner institutions propose the development of an NIMHD Center of Excellence (COE) with a focus on Women's Health Disparities. Consistent with the community-based participatory research (CBPR) focus of the TCHD, the focus on women's health was identified through substantial community dialogue with local and national partners. The proposed COE will focus on reducing health disparities by employing translational and CBPR approaches for identifying novel biomarkers for HIV-1 progression, developing detection and therapeutic strategies for triple negative breast cancer, and addressing weight loss and obesity. Our COE will augment and strengthen the existing infrastructure and capacity of the TCHD for conducting basic, clinical, translational, participatory, and socio-behavioral research. Our focus on Women's Health Disparities will address a significant need among racial and ethnic minority women in the U.S., the State of Texas, and our local community. We will also expand and develop new education and community outreach activities with our partner underrepresented minority (URM) institutions and community. The objectives of our COE are to: 1) Foster existing relationships and develop new relationships with URM institutions;2) Conduct impactful research on Women's Health Disparities addressing HIV prevention, breast cancer, and obesity reduction;3) Provide unique training and mentoring opportunities for URM students and faculty from URM institutions in health disparity research;4. Educate health professions trainees, health care practitioners and policy makers on the existence and need to address persistent health disparities;and, 5) Serve as a reliable resource for minority communities by disseminating health information, promoting participation in health education and research, and implementing disease prevention activities.

Public Health Relevance

The existence of health disparities in different racial, ethnic and socioeconomic groups in the United States is a significant public health concern. Through combined efforts of education, state of the art research and outreach to communities, the Texas Center for Health Disparities will help in combating this problem

National Institute of Health (NIH)
National Institute on Minority Health and Health Disparities (NIMHD)
Exploratory Grants (P20)
Project #
Application #
Study Section
Special Emphasis Panel (ZMD1-RN (01))
Program Officer
Tabor, Derrick C
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of North Texas
Other Domestic Higher Education
Fort Worth
United States
Zip Code
Griner, Nicholas B; Young, Denise; Chaudhary, Pankaj et al. (2015) ERG oncoprotein inhibits ANXA2 expression and function in prostate cancer. Mol Cancer Res 13:368-79
Rajendiran, Smrithi; Parwani, Anil V; Hare, Richard J et al. (2014) MicroRNA-940 suppresses prostate cancer migration and invasion by regulating MIEN1. Mol Cancer 13:250
Valapala, Mallika; Maji, Sayantan; Borejdo, Julian et al. (2014) Cell surface translocation of annexin A2 facilitates glutamate-induced extracellular proteolysis. J Biol Chem 289:15915-26
Chaudhary, Pankaj; Vishwanatha, Jamboor K (2014) c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine. Biochem Pharmacol 91:457-73
Chaudhary, Pankaj; Sharma, Rajendra; Sahu, Mukesh et al. (2013) 4-Hydroxynonenal induces G2/M phase cell cycle arrest by activation of the ataxia telangiectasia mutated and Rad3-related protein (ATR)/checkpoint kinase 1 (Chk1) signaling pathway. J Biol Chem 288:20532-46